Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Matza, Louis S.
Boye, Kristina S.
Stewart, Katie D.
Davies, Evan W.
Funding for this research was provided by:
Eli Lilly and Company (NA)